UMDNJ - NJ Medical School
Welcome,         Profile    Billing    Logout  
 2 Trials 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Markowitz, John
NCT03781752: Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHD

Recruiting
4
500
US
Methylphenidate, d,l-methylphenidate, MPH
Icahn School of Medicine at Mount Sinai, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), University of Florida, Children's Hospital Medical Center, Cincinnati, Seattle Children's Hospital
ADHD, Attention Deficit Hyperactivity Disorder
08/25
08/25
IPT, NCT04973930: Feasibility Trial of Tele- and Tele-Pharmacotherapy for Patients With Depression and Non-Metastatic Breast Cancer

Active, not recruiting
3
20
US
Interpersonal Psychotherapy, IPT, Venlafaxine HCl ER, Escitalopram Oral Tablet
New York State Psychiatric Institute, Columbia University
Major Depressive Disorder, Breast Cancer, Venlafaxine
12/25
12/25
Uhde, Thomas W
NCT05156047: A Phase 3 Study to Assess the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia

Completed
3
214
US
Open-label pitolisant, Double-blind placebo, Double-blind pitolisant
Harmony Biosciences, LLC
Idiopathic Hypersomnia
09/23
09/23
SUVN-G3031, NCT04072380: A Study to Evaluate Safety, and Efficacy of (Samelisant) in Patients With Narcolepsy With and Without Cataplexy

Completed
2
190
Canada, US
SUVN-G3031, Samelisant, Placebo
Suven Life Sciences Limited
Narcolepsy
06/23
06/23
NCT05668754: Placebo-Controlled, Double-Blind, Study to Determine the Safety and Efficacy of SDX in Patients With IH

Completed
2
50
US
Serdexmethylphenidate, SDX, Placebo
Zevra Therapeutics, Rho, Inc.
Idiopathic Hypersomnia
02/24
03/24

Download Options